. P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron. 2024 May 15;112(10):1676-1693.e12. Epub 2024 Mar 20 PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. We are very pleased that our study uploaded on bioRxiv, on proteostasis as a fundamental principle of Tau immunotherapy, is now out in the journal Brain.

    References:

    . Proteostasis as a fundamental principle of Tau immunotherapy. Brain. 2025 Jan 7;148(1):168-184. PubMed.

    View all comments by Jürgen Götz

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. p-Tau217 Immunotherapy Alleviates Tangle Pathology in Mice